Latham & Watkins LLP represented Zentalis Pharmaceuticals in the offering. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting...
Zentalis Pharmaceuticals’ $150.4 Million Common Stock Offering
Monte Rosa Therapeutics’ $222.3 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Monte Rosa Therapeutics, Inc. executed its initial public offering of 11,700,000 shares of common stock at a...
WalkMe’s $287 Million Initial Public Offering
Latham & Watkins LLP represented WalkMe in the offering. WalkMe Ltd., a leading provider of digital adoption solutions, has announced the pricing of its initial public...
WalkMe’s $287 Million Initial Public Offering
Latham & Watkins LLP represented WalkMe in the offering. WalkMe Ltd., a leading provider of digital adoption solutions, has announced the pricing of its initial public...
ATAI Life Sciences’ Initial Public Offering
Dentons and Latham & Watkins advised ATAI Life Sciences on the deal, while Davis Polk advised the underwriters. Clinical-stage biopharmaceutical company ATAI Life Sciences launched its...
Global-e Online’s Initial Public Offering
Latham & Watkins advised Global-e Online on the deal. Global-e Online (Global-e), the world’s leading platform to enable and accelerate global, direct-to-consumer cross-border e-commerce, executed its...
Similarweb’s Initial Public Offering
Latham & Watkins advised the underwriters on the deal. Similarweb Ltd. (Similarweb) executed its initial public offering of an aggregate of 8,000,000 ordinary shares at a price...
Roivant Sciences Ltd.’s Merger with Montes Archimedes Acquisition Corp.
Conyers and Davis Polk & Wardwell is advising Roivant Sciences Ltd., in its business combination by merger of a subsidiary with Montes Archimedes Acquisition Corp. (MAAC)...
Outset Medical’s Primary and Upsized Secondary Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Sidley Austin LLP advised Outset Medical, Inc. Outset Medical, Inc., a medical technology company pioneering...
Achilles Therapeutics’ $175.5 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Goodwin Procter LLP advised Achilles Therapeutics plc. Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing...
Instil Bio’s $320 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Instil Bio, Inc. executed its upsized initial public offering of 16 million shares of common stock at...
Athenex’s $110 Million Common Stock Offering
Latham & Watkins LLP represented the underwriters in the offering of Athenex, assisted by Harter Secrest & Emery LLP. Athenex, Inc. announced the pricing of a...